The early second hit in trauma management augments the proinflammatory immune response to multiple injuries

Journal of Trauma - Injury, Infection and Critical Care

Volumn 62, Issue 6, 2007, Pages 1396-1403

  Tschoeke, Sven K ^a   Hellmuth, Markus ^a   Hostmann, Arwed ^a   Ertel, Wolfgang ^a   Oberholzer, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

IL 10; IL 6; Inflammation; Multiple injuries; Sepsis; SIRS; sTREM 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN; SOLUBLE TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELL 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMERGENCY SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FACE INJURY; FEMALE; HEAD INJURY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INJURY SEVERITY; LIMB INJURY; MALE; MULTIPLE TRAUMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; ROOM TEMPERATURE; SCORING SYSTEM; SPINE INJURY; THORAX INJURY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE TRAUMA; RECEPTORS, IMMUNOLOGIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 34250317323     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318047b7f0     Document Type: Article

References (53)

1. Hietbrink F, Koenderman L, Rijkers G, et al. Trauma: the role of the innate immune system. World J Emerg Surg. 2006;1:15.
2. Yao YM, Redl H, Bahrami S, et al. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998;47:201-210.
3. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691-709.
4. Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994;15:74-80.
5. Gebhard F, Pfetsch H, Steinbach G, et al. Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg. 2000;135:291-295.
6. Oberholzer A, Souza SM, Tschoeke SK, et al. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock. 2005;23:488-493.
7. Svoboda P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma. 1994;36:336-340.
8. Hensler T, Heinemann B, Sauerland S, et al. Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock. 2003;20:497-502.
9. Menger MD, Vollmar B. Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg. 2004;389:475-484.
10. Pape HC, van Griensven M, Rice J, et al. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers. J Trauma. 2001;50:989-1000.
11. Gletsu N, Lin E, Zhu JL, et al. Increased plasma interleukin 6 concentrations and exaggerated adipose tissue interleukin 6 content in severely obese patients after operative trauma. Surgery. 2006;140:50-57.
12. Murphy TJ, Paterson HM, Kriynovich S, et al. Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J Leukocyte Biol. 2005;77:16-23.
13. van Griensven M, Kuzu M, Breddin M, et al. Polymicrobial sepsis induces organ changes due to granulocyte adhesion in a murine two hit model of trauma. Exp Toxicol Pathol. 2002;54:203-209.
14. Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis. 2003;187(Suppl 2):S397-S401.
15. Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 2003;170:3812-3818.
16. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991-4995.
17. Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103-1107.
18. Radsak MP, Salih HR, Rammensee HG, et al. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 2004;172:4956-4963.
19. Gibot S, Cravoisy A, Kolopp-Sarda MN, et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med. 2005;33:792-796.
20. Baker SP, O'Neill B, Haddon W Jr, et al. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
21. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-84.
22. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995;107:1062-1073.
23. Nast-Kolb D, Waydhas C, Gippner-Steppert C, et al. Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma. 1997;42:446-454; discussion 454-445.
24. Claridge JA, Weed AC, Enelow R, et al. Laparotomy potentiates cytokine release and impairs pulmonary function after hemorrhage and resuscitation in mice. J Trauma. 2001;50:244-252.
25. Kaneko A, Kido T, Yamamoto M, et al. Intestinal anastomosis surgery with no septic shock primes for a dysregulatory response to a second stimulus. J Surg Res. 2006;134:215-222.
26. Schulman AM, Claridge JA, Ghezel-Ayagh A, et al. Differential local and systemic tumor necrosis factor-alpha responses to a second hit of lipopolysaccharide after hemorrhagic shock. J Trauma. 2003;55:298-307.
27. Giannoudis PV, Smith RM, Bellamy MC, et al. Stimulation of the inflammatory system by reamed and unreamed nailing of femoral fractures. An analysis of the second hit. J Bone Joint Surg. 1999;81:356-361.
28. Ogura H, Tanaka H, Koh T, et al. Priming, second-hit priming, and apoptosis in leukocytes from trauma patients. J Trauma. 1999;46:774-781; discussion 781-773.
29. Pape HC, Grimme K, Van Griensven M, et al. Impact of intramedullary instrumentation versus damage control for femoral fractures on immunoinflammatory parameters: prospective randomized analysis by the EPOFF Study Group. J Trauma. 2003;55:7-13.
30. Arand M, Melzner H, Kinzl L, et al. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbecks Arch Surg. 2001;386:241-248.
31. Yang YH, Toh ML, Clyne CD, et al. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1. J Immunol. 2006;177:8148-8153.
32. Brand A. Immunological aspects of blood transfusions. Transpl Immunol. 2002;10:183-190.
33. Johnson JL, Moore EE, Gonzalez RJ, et al. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J Trauma. 2003;54:133-139; discussion 139-140.
34. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma. 1995;39:879-885; discussion 885-877.
35. Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863-870; discussion 870-861.
36. Giannoudis PV, Smith RM, Perry SL, et al. Immediate IL-10 expression following major orthopaedic trauma: relationship to antiinflammatory response and subsequent development of sepsis. Intensive Care Med. 2000;26:1076-1081.
37. Majetschak M, Flach R, Kreuzfelder E, et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med. 1999;27:313-318.
38. Muehlstedt SG, Lyte M, Rodriguez JL. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock. 2002;17:443-450.
39. Nicholson G, Woodfine J, Bryant AE, et al. The hormonal and inflammatory responses to pelvic reconstructive surgery following major trauma. Injury. 2005;36:303-309.
40. Pavlov VA, Wang H, Czura CJ, et al. The cholinergic antiinflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9:125-134.
41. Tracey KJ. The inflammatory reflex. Nature. 2002;420:853-859.
42. Roszman T, Elliott L, Brooks W. Modulation of T-cell function by gliomas. Immunol Today. 1991;12:370-374.
43. Madden KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol. 1995;35:417-448.
44. Celada A, Nathan C. Macrophage activation revisited. Immunol Today. 1994;15:100-102.
45. Woiciechowsky C, Asadullah K, Nestler D, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808-813.
46. Woiciechowsky C, Schoning B, Lanksch WR, et al. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med. 1999;77:769-780.
47. Flohe S, Lendemans S, Schade FU, et al. Influence of surgical intervention in the immune response of severely injured patients. Intensive Care Med. 2004;30:96-102.
48. Koussoulas V, Vassiliou S, Demonakou M, et al. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease. Eur J Gastroenterol Hepatol. 2006;18:375-379.
49. Tzivras M, Koussoulas V, Giamarellos-Bourboulis EJ, et al. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J Gastroenterol. 2006;12:3416-3419.
50. Gibot S, Kolopp-Sarda MN, Bene MC, et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med. 2004;200:1419-1426.
51. Mahdy AM, Lowes DA, Galley HF, et al. Production of soluble triggering receptor expressed on myeloid cells by lipopolysaccharide-stimulated human neutrophils involves de novo protein synthesis. Clin Vaccine Immunol. 2006;13:492-495.
52. Giamarellos-Bourboulis EJ, Zakynthinos S, Baziaka F, et al. Soluble triggering receptor expressed on myeloid cells 1 as an antiinflammatory mediator in sepsis. Intensive Care Med. 2006;32:237-243.
53. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol. 2005;16(Suppl 1):S83-S88.